Response to Comment “Evaluation of Aspirin Use for Primary Prevention in Diabetic Patients”

Abstract

Get full access to this article

View all access options for this article.

References

Miyares

Davis

. Evaluation of aspirin use for primary prevention in diabetic patients. Ann Pharmacother. 2015;49:150-151.

Fosmire Rundgren

Anderson

Marrs

. Evaluation of aspirin use in patients with diabetes receiving care in community health. Ann Pharmacother. 2015;49:170-177.

American Diabetes Association. Standards of Medical Care in Diabetes-2014. Diabetes Care. 2014;37(suppl 1):S14-S80.

Goff

Jr Lloyd-Jones

Bennett

. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(suppl 2):S49-S73.

American Diabetes Association. Standards of medical care in diabetes: 2012. Diabetes Care. 2012;35(suppl 1):S11-S63.

Ogawa

Nakayama

Morimoto

; Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2008;300:2134-2141.

Belch

MacCuish

Campbell

. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ. 2008;337:a1840.

University of Vigo. Chronotherapy with low-dose aspirin for primary prevention (CARING). http://www.clinical-trials.gov/ct2/show/NCT00725127. Accessed November 12, 2014.

University of Oxford. ASCEND: A Study of Cardiovascular Events iN Diabetes. http://www.clinicaltrials.gov/ct2/show/NCT00135226. Accessed November 12, 2014.

10.

De Berardis

Sacco

Evangelista

. Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials. 2007;8:21.